|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.620 CNY | +4.46% |
|
+6.24% | -23.74% |
| 06-01 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| 05-07 | Beijing SL Pharmaceutical Gets China Regulatory Nod for Xinfer Drug | MT |
| Market Cap | 5.77B 856M 740M 689M 633M 1.2B 81.66B 1.22B 8.12B 3.18B 40.63B 3.21B 3.14B 135B | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 4.63B 687M 594M 553M 508M 960M 65.51B 976M 6.52B 2.55B 32.6B 2.58B 2.52B 108B | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.66% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 day | +4.46% | ||
| 1 week | +6.24% | ||
| 1 month | -10.51% | ||
| 3 months | -13.41% | ||
| 6 months | -26.73% | ||
| Current year | -23.74% |
| 1 week | 5.22 |  | 5.7 |
| 1 month | 5.2 | | 7.33 |
| Current year | 4.81 | | 9.4 |
| 1 year | 4.81 | | 9.4 |
| 3 years | 4.81 | | 16.09 |
| 5 years | 4.81 | | 16.09 |
| 10 years | 4.81 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 11/04/2006 |
Li Ji
DFI | Director of Finance/CFO | 45 | 24/04/2023 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 11/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 11/04/2006 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 24/04/2009 |
Yu Lin Chen
BRD | Director/Board Member | 81 | 11/04/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/5/25 A | Buy | Director | 100 | 0.0000% | ||
| 10/29/25 A | Sell | Director | 35,100 | 0.0041% | ||
| 10/28/25 A | Sell | Director | 340,000 | 0.0399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.46% | +6.24% | -32.61% | -41.03% | 855M | |
| -0.53% | -3.95% | +50.70% | +153.56% | 1,024B | |
| +0.21% | -2.68% | +53.20% | +51.79% | 618B | |
| -2.51% | -3.25% | +28.54% | +68.94% | 443B | |
| +0.06% | -0.42% | +37.53% | +30.67% | 349B | |
| -0.69% | -0.30% | +13.76% | +12.83% | 264B | |
| -7.37% | -4.40% | -0.74% | -44.28% | 209B | |
| -0.64% | +2.43% | +29.74% | +65.93% | 208B | |
| -0.82% | +0.70% | +15.05% | +72.05% | 162B | |
| +0.40% | +1.92% | +6.47% | -29.77% | 143B | |
| Average | -0.74% | -1.00% | +20.16% | +34.07% | 341.98B | |
| Weighted average by Cap. | -1.00% | -2.01% | +36.12% | +71.87% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 660M 97.92M 84.62M 78.8M 72.4M 137M 9.34B 139M 929M 364M 4.65B 368M 360M 15.41B | 624M 92.46M 79.9M 74.41M 68.37M 129M 8.82B 131M 877M 344M 4.39B 347M 340M 14.55B |
| Net income | -74.07M -10.98M -9.49M -8.84M -8.12M -15.35M -1.05B -15.6M -104M -40.84M -521M -41.24M -40.33M -1.73B | -347M -51.48M -44.48M -41.43M -38.06M -71.97M -4.91B -73.13M -488M -191M -2.44B -193M -189M -8.1B |
| Net Debt | -1.98B -294M -254M -237M -217M -411M -28.03B -418M -2.79B -1.09B -13.95B -1.1B -1.08B -46.25B | -1.14B -169M -146M -136M -125M -237M -16.14B -240M -1.61B -629M -8.03B -635M -622M -26.63B |
Employees
901
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | CN¥5.620 | +4.46% | 36,196,367 |
| 30/07/26 | CN¥5.380 | -2.00% | 34,326,701 |
| 29/07/26 | CN¥5.490 | -.--% | 30,713,907 |
| 28/07/26 | CN¥5.490 | -1.44% | 32,161,652 |
| 27/07/26 | CN¥5.570 | +5.29% | 40,087,736 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Select your edition
All financial news and data tailored to specific country editions
